Access To Medicines Foundation Details Methodology For 2018 AMR Benchmark 24/08/2017 by Intellectual Property Watch Leave a Comment The Amsterdam-based Access to Medicines Foundation today published the methodology it will use for its 2018 framework for evaluating how pharmaceutical companies are taking action to limit antimicrobial resistance, addressing the rising the global problem of overuse of antibiotics leading to resistance with few new ones in the pipeline.
Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 by William New, Intellectual Property Watch Leave a Comment A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases.
The Case For Nations To Act On Medicines Access 23/07/2017 by William New, Intellectual Property Watch 2 Comments NEW YORK — A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead?
More Than Half Of People With HIV Now Have Access To Treatment, UNAIDS Says 20/07/2017 by Intellectual Property Watch Leave a Comment For the first time, more than half of people in the world living with HIV have access to treatment, UNAIDS said in a report released today in Geneva. In addition, AIDS-related deaths have been nearly cut in half since 2005, it said. As of 2016, nearly 20 million people were living with HIV.
WHO Influenza Watchdog Network Meeting In Geneva, Setting 5-Year Plan 18/07/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained.
WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors.
WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 by Elise De Geyter for Intellectual Property Watch Leave a Comment The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation.
Access To Medicines For All By 2030: New WHO Strategic Framework Sets Vision 13/07/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Access to affordable and quality medicines for all is one of the major commitments of the World Health Organization, and its new medicines and health products strategic framework for the next 15 years calls for new research and development (R&D) models, including delinkage of the R&D costs from the price of products, and fair pricing.
Health: Report Calls For Increased Efforts On TB; WHO Warns About Antibiotic-Resistant Sexually Transmitted Disease 07/07/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Tuberculosis is still a deadly killer, and a new report by two humanitarian organisations raises alarm on poor progress on the disease diagnosis and treatment. The report calls for governments to increase efforts to fight the disease, and for the G20 countries to mobilise funds to help, in particular to boost research and development for new treatments. Separately, the World Health Organization issued a call for new treatments to fight antibiotic resistant gonorrhoea.
G20: Security, Trade, Climate, Trump Diplomacy Overshadow Health, IT, Innovation 07/07/2017 by Monika Ermert for Intellectual Property Watch Leave a Comment On the eve of the G20 meeting in Hamburg, Germany, German politicians described positions on free trade and climate as the most difficult issues. Expectations from civil society groups in the G20 results are modest at best and the 6 July protest march “Welcome to Hell” was cancelled after clashes between the police and parts of the protestors.
